%PDF-1.4
%
66 0 obj
<>
endobj
63 0 obj
<>
endobj
108 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-09-08T17:47:24Z
2024-03-28T18:52:27-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T18:52:27-07:00
application/pdf
Heather
2002-798.oct
uuid:2a579475-1dd2-11b2-0a00-2209271d5700
uuid:2a579478-1dd2-11b2-0a00-bf0000000000
endstream
endobj
52 0 obj
<>
endobj
53 0 obj
<>
endobj
67 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 36 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 38 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 40 0 R/Type/Page>>
endobj
20 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 42 0 R/Type/Page>>
endobj
23 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 44 0 R/Type/Page>>
endobj
26 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 46 0 R/Type/Page>>
endobj
134 0 obj
[138 0 R]
endobj
135 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
8 0 0 8 74.4 714.5293 Tm
(1997;36:781-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(19.)-875.1 (Cimmino MA, Parisi M, Moggiana G, Mela GS, )54.8 (Accardo S.)]TJ
2.175 -1.25 Td
[(Prevalence of rheumatoid arthritis in Italy: the Chiavari Study)64.8 (. )54.8 (Ann)]TJ
0 -1.25 TD
(Rheum Dis 1998;57:315-8.)Tj
-2.175 -1.25 Td
[(20.)-875.1 (Carmona L, )17.7 (V)59.8 (illaverde )17.7 (V)128.9 (, Hernandez-Garcia C, Ballina J, Gabriel)]TJ
2.175 -1.25 Td
[(R, Laf)17.7 (fon )54.8 (A. )17.7 (The prevalence of rheumatoid arthritis in the general)]TJ
T*
(population of Spain. Rheumatology 2002;41:88-95.)Tj
-2.175 -1.25 Td
[(21.)-875.1 (van der Linden SM, )17.7 (V)110.8 (alkenbur)17.7 (g HA, de Jongh BM, Cats )54.8 (A. )17.7 (The)]TJ
2.175 -1.25 Td
(risk of developing ankylosing spondylitis in HLA-B27 positive)Tj
T*
[(individuals. )54.8 (A)-220.1 (comparison of relatives of spondylitis patients with)]TJ
T*
[(the general population. )54.8 (Arthritis Rheum 1984;27:241-9.)]TJ
-2.175 -1.25 Td
[(22.)-875.1 (Braun J, Bollow M, Remlinger G, et al. Prevalence of )]TJ
2.175 -1.25 Td
(spondylarthropathies in HLA-B27 positive and negative blood)Tj
T*
[(donors. )54.8 (Arthritis Rheum 1998;41:58-67.)]TJ
-2.175 -1.25 Td
[(23.)-875.1 (Gofton JP)110.7 (, Bennett PH, Smythe HA, Decker JL. Sacroiliitis and)]TJ
2.175 -1.25 Td
[(ankylosing spondylitis in North )54.8 (American Indians. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(1972;31:474-81.)Tj
0.02499 Tw -2.175 -1.25 Td
[(24.)-875 (Chen SL, Xue BQ, Bao CD, Liu QY)128.9 (. COPCORD study in)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(Shanghai. In: Nasution )54.8 (AR, Darmawan J, editors. )54.8 (APLAR)]TJ
T*
[(Rheumatology)64.9 (. )17.7 (T)69.9 (okyo: Churchill Livingstone; 1992:393-5.)]TJ
-2.175 -1.25 Td
[(25.)-875.1 (Harris CM, Lloyd DC, Lewis J. )17.7 (The prevalence and prophylaxis of)]TJ
2.175 -1.25 Td
[(gout in England. J Clin Epidemiol 1995;48:1)36.8 (153-8.)]TJ
30.825 26.25 Td
[(26.)-875.1 (Currie )17.7 (WJ. Prevalence and incidence of the diagnosis of gout in)]TJ
0 Tc 2.175 -1.25 Td
[(Great Britain. )54.8 (Ann Rheum Dis 1979;38:101-6.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(27.)-875.1 (Gibson )17.7 (T)74 (,)-0.1 ( )17.7 (W)79.9 (aterworth R, Hatfield P)110.7 (, Robinson G, Bremner K.)]TJ
2.175 -1.25 Td
(Hyperuricaemia, gout and kidney function in New Zealand Maori)Tj
T*
(men. Br J Rheumatol 1984;23:276-82.)Tj
-2.175 -1.25 Td
[(28.)-875.1 (Farooqi )54.8 (A, Gibson )17.7 (T)74 (. Prevalence of the major rheumatic disorders)]TJ
2.175 -1.25 Td
(in the adult population of north Pakistan. Br J Rheumatol)Tj
0 Tc 0 Tw T*
(1998;37:491-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(29.)-875.1 (Chaiamnuay P)110.8 (, Darmawan J, Muirden KD, )54.8 (Assawatanabodee P)110.7 (.)]TJ
2.175 -1.25 Td
[(Epidemiology of rheumatic disease in rural )17.7 (Thailand: a )]TJ
T*
[(WHO-ILAR COPCORD study)64.9 (. Community Oriented Programme)]TJ
T*
(for the Control of Rheumatic Disease. J Rheumatol )Tj
0 Tc 0 Tw T*
(1998;25:1382-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(30.)-875.1 (Darmawan J, )17.7 (V)110.8 (alkenbur)17.7 (g HA, Muirden KD, )17.7 (W)39.9 (igley RD.)]TJ
2.175 -1.25 Td
(Epidemiology of rheumatic diseases in rural and urban populations)Tj
T*
[(in Indonesia: a )17.7 (W)79.9 (orld Health Or)17.7 (ganisation International League)]TJ
T*
[(Against Rheumatism COPCORD study)64.8 (, stage I, phase 2. )54.8 (Ann)]TJ
T*
(Rheum Dis 1992;51:525-8.)Tj
-2.175 -1.25 Td
[(31.)-875.1 (Stojanovic R, )17.7 (Vlajinac H, Palic-Obradovic D, Janosevic S, )54.8 (Adanja)]TJ
2.175 -1.25 Td
[(B. Prevalence of rheumatoid arthritis in Belgrade, )36.8 (Y)110.8 (ugoslavia. Br )]TJ
T*
(J Rheumatol 1998;37:729-32.)Tj
/T1_1 1 Tf
-35.4875 -59.8181 Td
(Dai, et al: Rheumatic disease in China)Tj
0 Tc 0 Tw 60.9375 -0.0313 Td
(2251)Tj
ET
0 0 0 1 K
55 54 m
559 54 l
S
0 0 0 0 k
/GS0 gs
109.22 59.09 396.48 -10.84 re
f*
0.5 w
109.22 59.09 396.48 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
46 0 obj
<>stream
8;Z\uCC\6)%"iX$$g'KKJN.7,;()3MP!;Z?CK'CbW4NUjL/i+4fB':dCGW,;#1If?
V:j:c<*O5\=6lRq^\0=f*El1:"u&[OmcOL(5QknBobOK-Uumn:De5Cj3QgEjE`o_p
K:6;PMeT_$K@Ji6\Gh4oVF0`?pPmtr;gX;PQrFn0.mduH4aT!nQ#9gWQdfJd@Mj!k
@UF:#Wc&mf)!sO=j;,]b?=kjEdR9cVE'si.rs43L,?FSX_\Xs1GaiJ
%$(;
endstream
endobj
50 0 obj
[/Indexed/DeviceRGB 255 49 0 R]
endobj
49 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
73 0 obj
<>
endobj
70 0 obj
<>
endobj
93 0 obj
<>
endobj
113 0 obj
<>
endobj
69 0 obj
<>
endobj
86 0 obj
<>stream
HUkPg>nۇ܄VEխ7(K$BpI BH$!@%ȥ`b륖zGk:]fJK_vvΙysy܌aSȾ!VGr9{ iܣhwhO^j9ochcN{8(/g;hc-09?~~ylnr75
ID/{23y N/5-9ٹ웉\>;-NH'dgC<09|n7!Vg``ؚ12
fm$#Ԛ1c3#xa9mɬƃ?5WK_ HFM!>+xx|Xý(˼R_OHV蛇ui7:JтqB*Fޡ*E^(#sEb\ETڋUxgq)3LLkztEۜQ(I@f*yu0zv5n{ّ}"ڂ%z`TKp@YkLE.[z(MT$_/) /JGc2KR\YjL\*(I-+ϵԼhmF"j>X S!KU*e2~ z8kL-z-"ȁN$^1' _&t("C)Ä`SLD/ߡB92q۵])ixgUDZ.P{䰞"Ejv}yLV->pQ}5z$ՙYh!0{{㒓D |94V&W!lV[ K!&av9b9i U
y/lJk
"Y-rn -k]H,HdNFnUfhwh36
S?Chсݑ{t+EGIawҥqGOhpoGеy\36S|ko2|$vm´|tA(m~ڦ;#;=C mIP㴃{xzY7oLa*/M
]Yy2$EF;!CP^Tt뼾!
9##|5qrmK"|./&<\M!/<67)
oX`'We&AvK0nMb+ i,>{OZ=nPҔM&51K&.GfV+铏7w4Ս?Ry+]
"ag
U蠻;C(/Ihݾo(-=%UI\d/FAlQ@g@$2+B=KU{}@lwz4vq@WGi\"f
dڢRuF}.Z㴃1Z4HTBՅj-bx=^!f+ZAR2Պy'e^+b7@Q̷7y썫(Eט,V셼+tI+8cWضCnrj1M{(AR[VѨhOWG#3K(Q$7L[MqBlPwMt?ֿ@F;U^(8V^"ޡ0Yh9B+BP/=yT߮T7K
!ʣpc|Iુ>g3G:Vq
Ql *HB%vЂQ*"(jq0Lkcuq~ϼ@픙~=O6`}=].`Xi8a+r擜FhVFm
w`7p!v
XUK\u^~'@9
,ꗍk'خ
-+tˡZr*gf'nM@5)s l֑@wǷiDFq xI#{ O+5${4i
"obRyDA̙E+
эFzVwl{HȞJbaX?DvI' I19H5J":QhEYW! Yμ(_Dp1b{li
3SJ_gCgj%pjN',DA眒TNϰ<6DWq5Uj%cn2wfXؕL5\ϩdw:C}](Q?iOYm/pur>Ȧmޛv!N:ZZq¥ӨocOyklBywC}*=?jkН{lJ$O/j`1]-p/M SkVm( ҥVE[.gՄׇjOĻЁo-,6dcYw` {іRUPP(_ɫdF4GK)[Q1,/Ew/))G{"u'xyfmpi~8@7)Pb?0Xf''q|0E08RRZű|+syM Ll:bD=fuzi}sGa9rmt
Y0ژ\-UP4cJm^N}lLȯZ#u_h.g]
Y-?NqP[3f9Yp
ә
&s#;nL s8
>iҙLs7%%t35im 9F3]ʴr`Ȟ\au~:~oDz)}(1YnQi6%c^ (
K}j뙑M/36H?;My3gNhHHvbGƽ9TI?+[D00ځmٞ=eߘ܌>KlےZ5tXu%aBx+ҁ>=q
"! 걮Iw1؝ mCiF+FfߡIPVm 3%zI4n8ƨR"-ID)rZHqo13Y,e!|sb䜓Ȍ3ZeZ;%_j%&tΈM
./.,)dZUjeB!MZ$J,-hF*RnW6]LZ$WD0?<$1,z#6MYd$
!_!՞q>|9u(0,xnۢO??쨐9K<j>jՑn>?ݕ$tWZ`Ee[uKG"].g6HԱlDž>_ƟuU]\_9ZOK7$b|i8HSUd˥b*J8FberyM)QevVԒeg&05-|.\YStj2HHVfwEz
y=߀̦.qӿ-43j-a3KalZh]tqV5$NBk @EЖnlQxR/uܶnwvvcw u\3g<